ePosters
Continuous intravenous infusions of non-opioid analgesics can augment postoperative patient recovery [1, 2, 3]. Perioperative multimodal analgesic regimens help reduce adverse events, such as chronic post-surgical pain (CPSP) [4]. Dexmedetomidine stimulates α2 receptors and exerts both supraspinal and spinal mechanisms of analgesia [1]. Lidocaine affects NMDA, muscarinic M1/M3, 5-HT3 receptors, voltage-gated calcium channels, and may possess anti-inflammatory properties [2]. Ketamine inhibits NMDA receptors, but may also affect μ-opioid, muscarinic, and γ-aminobutyric acid receptors [3].
Yash Shah, M.D.
Resident
Brown University Health
Providence, Rhode Island, United States
Cheryl Prigiano, MS, ACNP-BC
Nurse Practitioner
Brown University Health, United States
Joshua Potvin, M.D.
Assistant Professor
Brown University Health, United States
Mark Kendall, M.D.
Director of Clinical Research
Brown University Health, United States
Vendhan Ramanujam, M.D.
Assistant Professor
Brown University Health, United States